1. Home
  2. WASH vs AKBA Comparison

WASH vs AKBA Comparison

Compare WASH & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Washington Trust Bancorp Inc.

WASH

Washington Trust Bancorp Inc.

HOLD

Current Price

$34.39

Market Cap

682.2M

Sector

Finance

ML Signal

HOLD

Logo Akebia Therapeutics Inc.

AKBA

Akebia Therapeutics Inc.

HOLD

Current Price

$1.25

Market Cap

729.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WASH
AKBA
Founded
1800
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
682.2M
729.1M
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
WASH
AKBA
Price
$34.39
$1.25
Analyst Decision
Hold
Strong Buy
Analyst Count
4
6
Target Price
$31.25
$5.75
AVG Volume (30 Days)
104.3K
3.3M
Earning Date
04-29-2026
05-27-2026
Dividend Yield
6.51%
N/A
EPS Growth
266.26
93.94
EPS
2.71
N/A
Revenue
$229,048,000.00
N/A
Revenue This Year
N/A
$1.84
Revenue Next Year
$6.19
N/A
P/E Ratio
$12.70
N/A
Revenue Growth
127.57
N/A
52 Week Low
$24.97
$1.14
52 Week High
$37.08
$4.08

Technical Indicators

Market Signals
Indicator
WASH
AKBA
Relative Strength Index (RSI) 51.59 43.18
Support Level $26.60 $1.14
Resistance Level $37.08 $1.57
Average True Range (ATR) 1.24 0.10
MACD -0.34 0.01
Stochastic Oscillator 51.66 22.83

Price Performance

Historical Comparison
WASH
AKBA

About WASH Washington Trust Bancorp Inc.

Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It offers a full range of financial services, including commercial banking, mortgage banking, personal banking, and wealth management and trust services, through its offices located in Rhode Island, Connecticut, and Massachusetts. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.

Share on Social Networks: